Who can apply?
The Atip-Avenir program is open to young scientists, regardless of nationality, who have obtained a PhD in science or an equivalent degree more than two years ago and less than eight years ago.
Exceptions may be granted for maternity leave (12 months per child), paternity leave and/or military service, as well as for clinicians (laureates from the Inserm Liliane Bettencourt school …) and hospital-university professionals.
The program is open to any researcher or research professor, regardless of their affiliated organization, and to any non-permanent researcher. Applications from doctors or pharmacists are encouraged.
Focus
- The candidate must have joined the host laboratory for less than 18 months and must not find a previous mentor there (potential exceptions for hospital-university profiles).
- The applicant cannot apply for more than two different Atip-Avenir calls.
- Laureates of a grant supporting young researchers for developing an independent project, similar to the ATIP-Avenir program, are not eligible (e.g. ANR JCJC or ERC grants).
- ATIP-Avenir laureates can candidate to similar programs, but cannot cumulate fundings.
- Candidates can submit their proposal without having an identified host laboratory.
What are the resources allocated?
- Package for 5 years (evaluation at mid-term) including:
- An annual grant of € 60,000
- Two-year salary for a postdoctoral researcher or an engineer.
- Five-year salary for non-tenured laureates.
- The host laboratory will provide a dedicated research area of at least 50 m2 (infrastructures fees will be covered by the host laboratory) and access to the local technological facilities to the Atip-Avenir team.
- Several partners support the program and are likely to co-fund projects related to their respective fields:
- Agence nationale de recherches sur le Sida et les hépatites virales | Maladies infectieuses émergentes (ANRS-MIE),
- Association française contre les myopathies (AFM-Téléthon),
- Fondation ARC pour la recherche sur le cancer,
- Fondation innovations en infectiologie (Finovi),
- Fondation Bettencourt Schueller, Ligue nationale contre le cancer (LNCC),
- Stratégie décennale de lutte contre les cancers 2021 – 2030,
- some of the Idex and I‑SITE.
Selection process
Initial screening and interview
The selection process occurs in two stages: an initial screening based on applications (usually in April), followed by an interview for shortlisted candidates (usually in June). The list of laureates and their host institutions is established jointly by Inserm and CNRS and published in early July.
Fields of research
Apllications are evaluated by international scientific committees covering the following fields of research:
Molecules of Life and Integrative Biology
- Molecular biology, biochemistry, structural biology, molecular biophysics, synthetic and chemical biology, drug design, innovative methods and modelling,
- Genetics, epigenetics, genomics and other ‘omics studies, bioinformatics, systems biology, genetic diseases, gene editing, innovative methods and modelling, ‘omics for personalized medicine.
Cell Biology, Development and Evolution
- Structure and function of the cell, cell-cell communication,
- Embryogenesis, tissue differentiation, organogenesis, growth, development, developmental and evolutionary genetics, organoids, stem cells,
- Regeneration, development of cell-based therapeutic approaches for tissue regeneration, Functional imaging of cells and tissues,
- Theoretical modelling in cellular, developmental and regenerative biology,
- Physics of biological systems,
- Non-canonical biological models and mechanisms.
Physiology, Pathophysiology, Immunity, Infection and Microbiology
- Organ and tissue physiology, comparative physiology, physiology of ageing, pathophysiology inter- organ and tissue communication,
- Endocrinology, nutrition, metabolism, interaction with the microbiome,
- Non-communicable diseases including cancer and immunity-related diseases (except disorders of the nervous system),
- The immune system, related disorders and their mechanisms,
- Innovative immunological tools and approaches, including therapies,
- Biology of infectious agents and infection, biological basis of prevention and treatment of infectious diseases,
- Pharmacology and toxicology,
- Nanomedicine, Technologies, genetic tools and biomarkers for prevention, diagnosis, monitoring and treatment of diseases.
Neurosciences and Cognition
- Nervous system development, homeostasis and ageing, nervous system function and dysfunction,
- Systems neuroscience and modelling, biological basis of cognitive processes and behavior,
- Neurological and mental disorders,
- Cognitive basis of human development, developmental disorders,
- Comparative cognition,
- Attention, perception, action, consciousness, learning, memory, cognition in ageing, reasoning, decision-making,
- Innovative methods and tools for neuroscience.
Contacts
Inserm
Elodie Mailler
ngvc-nirave@vafrez.se
CNRS
Catherine Cavard
ngvc-nirave@paef-qve.se
